Okubo, H.; Ando, H.; Nakadera, E.; Ikejima, K.; Shiina, S.; Nagahara, A.
Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. Nutrients 2021, 13, 4428.
https://doi.org/10.3390/nu13124428
AMA Style
Okubo H, Ando H, Nakadera E, Ikejima K, Shiina S, Nagahara A.
Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. Nutrients. 2021; 13(12):4428.
https://doi.org/10.3390/nu13124428
Chicago/Turabian Style
Okubo, Hironao, Hitoshi Ando, Eisuke Nakadera, Kenichi Ikejima, Shuichiro Shiina, and Akihito Nagahara.
2021. "Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis" Nutrients 13, no. 12: 4428.
https://doi.org/10.3390/nu13124428
APA Style
Okubo, H., Ando, H., Nakadera, E., Ikejima, K., Shiina, S., & Nagahara, A.
(2021). Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. Nutrients, 13(12), 4428.
https://doi.org/10.3390/nu13124428